Efinopegdutide vs Pemvidutide

Head-to-head comparison of Efinopegdutide (Efinopegdutide (HM12525A), long-acting glucagon-like peptide-1/glucagon receptor dual agonist) and Pemvidutide (Pemvidutide (ALT-801), long-acting glucagon-like peptide-1/glucagon receptor dual agonist) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyEfinopegdutidePemvidutide
CategoryWeight ManagementWeight Management
Full NameEfinopegdutide (HM12525A), long-acting glucagon-like peptide-1/glucagon receptor dual agonistPemvidutide (ALT-801), long-acting glucagon-like peptide-1/glucagon receptor dual agonist
Molecular WeightN/AN/A
Half-LifeApproximately 1 weekApproximately 1 week
Amino AcidsN/AN/A
Typical DoseTrial-dependent; weekly SC dosingTrial-dependent; once-weekly SC titration
RouteSubcutaneousSubcutaneous
Purity≥98%≥98%
Studies Count1418
Research StatusClinicalClinical

Efinopegdutide Benefits

  • reduced body weight
  • improved insulin sensitivity
  • reduced liver fat
  • greater satiety

Pemvidutide Benefits

  • appetite suppression
  • body-weight reduction
  • improved liver-fat markers
  • better glycemic control

Efinopegdutide Dosing

once-weekly subcutaneous injection|dose escalation during lead-in|maintenance dosing in trials

Pemvidutide Dosing

once-weekly subcutaneous injection|gradual dose escalation|maintenance at tolerated trial dose

Efinopegdutide Side Effects

  • nausea
  • decreased appetite
  • fatigue

Pemvidutide Side Effects

  • nausea
  • vomiting
  • diarrhea

Research Overview

Efinopegdutide

Human trials have shown meaningful weight loss and improvements in hepatic steatosis biomarkers. It remains a research compound with ongoing development in metabolic disease.

Pemvidutide

Clinical studies have reported dose-dependent weight loss and favorable effects on liver fat and transaminases. It remains investigational and is not approved for obesity treatment.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Efinopegdutide stacks with:

metforminorlistat

Pemvidutide stacks with:

metformintopiramate
glp1glucagondual-agonistobesitynashmash